Elite Pharmaceuticals, Inc. Operating Lease Liability
Elite Pharmaceuticals, Inc. (ELTP) had Operating Lease Liability of $1.42 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability $1.42M.
- 2026-03-31: Operating Lease, Liability $1.55M.
- 2025-12-31: Operating Lease, Liability $1.68M.
- 2025-09-30: Operating Lease, Liability $1.80M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $1.42M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.55M 10-K · filed 2026-06-29 | |
| 2025-12-31 | $1.68M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $1.80M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.91M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.02M 10-K · filed 2025-06-30 | |
| 2024-12-31 | $2.13M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $2.16M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $2.27M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.37M 10-K · filed 2024-07-01 | |
| 2023-12-31 | $26.23K 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $2.16K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $8.59K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.16K 10-Q · filed 2023-11-14 | $14.91K 10-K · filed 2023-06-29 |
| 2022-12-31 | $21.15K 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $27.23K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $989.61K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $1.04M 10-K · filed 2022-06-29 | |
| 2021-12-31 | $1.09M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $1.15M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.21M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $226.96K 10-K · filed 2021-06-14 | |
| 2020-12-31 | $221.17K 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $273.31K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $1.21M 10-Q · filed 2021-08-16 | $324.68K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $375.29K 10-K · filed 2020-06-29 | |
| 2019-12-31 | $425.15K 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $473.18K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $520.50K 10-Q · filed 2019-08-09 | |
| 2019-04-02 | $600.00K 10-K · filed 2020-06-29 | $191.82K 10-Q · filed 2019-08-09 |